Treatment of severe falciparum malaria: quinine versus artesunate
Abstract
Background: Malaria is the most important disease of human being. More than 40% of the world’s population is considered to be at risk of exposure of this disease. Malaria infection has been increasing over recent years due to combination of factors including increasing resistance of malarial parasite. Most of the strains of P. falciparum are now resistance to conventional drugs like chloroquine in many areas. The objective of this study was to compare the efficacy and safety of quinine and artesunate in treatment of P. falciparum malaria.
Methods: This is hospital based prospective study, conducted amongst 35 randomly selected patients of severe P. falciparum malaria. Patients with any contraindications of either drug were excluded to avoid bias. Standard statistical tests were applied for qualitative as well as quantitative data.
Results: As per the study end point results of difference of mortality in patients receiving either drug was not significant (p > 0.75), but difference in clinical parameters like fever clearance time (p <0.01), parasite clearance time (p < 0.001) and coma resolution time (p < 0.001) were significant among patients receiving artesunate. There were no any significant differences in adverse effects of both the drugs. Mortality was same in both arms taking either drug.
Conclusions: Artesunate is as good as quinine in mortality aspect but artesunate is superior in fever clearance time (FCT) & parasite clearance time (PCT). Coma resolution time is faster with quinine as compared to artesunate. There are no significant adverse effects of either drug. So artesunate is equivalent or superior for treatment for severe falciparum malaria.
Keywords
Full Text:
PDFReferences
Epidemiology of communicable diseases, in Park’s textbook of preventive and social medicine. K. Park (Ed) 18th edition. Jabalpur, Banarasidas Bhanot Publish. 2008:198-200.
Roberts L. Mosquitoes and disease. Science 2002;298:82-3.
Hemingway J, Field L, Vontas J. An overview of insecticide resistance. Science 2002;298:96-7.
National anti-malaria programme: Strategy and Policies. In malaria and its control in India. Country Scenario: March 1999. National Anti-Malarial Programme (NAMP), DGHS, Govt. of India, 1999:1-11.
Sachs J, Malaney P. The economic and social burden of malaria. Nature 2002;415:680-5.
Sachs JD. A new global effort to control malaria. Science 2002;298:122-4.
Kyes S, Horrocks P, Newbold C. Antigenic variation at the infected red cell surface in malaria. Annu Rev Microbiol 2001;55:673-707.
Greenwood B, Mutabingwa T. Malaria in 2002. Nature 2002;415:670-2.
White NJ. The treatment of malaria. N Engl J Med 1996;335:800-6.
Pinswadi K, Chaereonkwan P. Sluggish response of a case of falciparum malaria to intensive quinine therapy. J Med Assoc Thai 1965;48:386.
Barradell LB, Fitton A. Artesunate. Drugs 1995;50:714-41.
World Health Organization. Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg 1990;84 Suppl 2:1-65.